Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 27Observational 2

Sponsor

Cancer Type

Gastrointestinal 26Thoracic 20Tumor-Agnostic 3Head & Neck 2Breast 2Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1

Interventions

Surveys and Questionnaires 40Blood Specimen Collection 30Radiotherapy 20Immunohistochemistry 13Gene Expression Profiling 12Radiotherapy, Intensity-Modulated 11Cisplatin 11Surgical Procedures, Operative 10Biopsy 10Drug Therapy 9Cetuximab 9Ultrasonography 8Thyroidectomy 8Observation 8Transurethral Resection of Prostate 7Nivolumab 7Interviews as Topic 7pembrolizumab 6Therapeutics 6Radiation 6Polymerase Chain Reaction 6Immunotherapy 6Biopsy, Fine-Needle 6Positron Emission Tomography Computed Tomography 5Microarray Analysis 5Liquid Biopsy 5Iodine-131 5Docetaxel 5Chemoradiotherapy 5Tissue Banks 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Immune Checkpoint Inhibitors × Head & Neck × Clear all
NCT07618078 2026-06-03

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
900 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Zhujiang Hospital

Not yet recruiting
85 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡